Stocks and InvestingStocks and Investing
Fri, June 30, 2023
Thu, June 29, 2023
Wed, June 28, 2023

Phil Nadeau Maintained (VRTX) at Buy with Increased Target to $360 on, Jun 28th, 2023


Published on 2024-10-28 04:34:20 - WOPRAI, Phil Nadeau
  Print publication without navigation


Phil Nadeau of TD Cowen, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $350 to $360 on, Jun 28th, 2023.

Phil has made no other calls on VRTX in the last 4 months.



There are 19 other peers that have a rating on VRTX. Out of the 19 peers that are also analyzing VRTX, 4 agree with Phil's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Reiterated at Hold and Held Target at $323 on, Thursday, June 22nd, 2023
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $340 on, Tuesday, May 2nd, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $305 on, Tuesday, May 2nd, 2023
  • Brian Skorney of "Baird" Maintained at Hold with Increased Target to $325 on, Tuesday, May 2nd, 2023


These are the ratings of the 15 analyists that currently disagree with Phil


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $380 on, Monday, June 26th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $379 on, Monday, June 26th, 2023
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $365 on, Friday, June 23rd, 2023
  • Myles Minter of "William Blair" Initiated at Buy on, Tuesday, May 30th, 2023
  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $385 on, Thursday, May 4th, 2023
  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $400 on, Wednesday, May 3rd, 2023
  • William Pickering of "Bernstein" Maintained at Buy with Increased Target to $363 on, Wednesday, May 3rd, 2023
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $456 on, Tuesday, May 2nd, 2023
  • Jessica Fye of "JP Morgan" Maintained at Buy and Held Target at $345 on, Tuesday, May 2nd, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $399 on, Tuesday, May 2nd, 2023
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $385 on, Tuesday, May 2nd, 2023
  • Evan Seigerman of "BMO Capital" Maintained at Buy and Held Target at $385 on, Tuesday, May 2nd, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $384 on, Tuesday, May 2nd, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $410 on, Tuesday, May 2nd, 2023
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Wednesday, March 29th, 2023